In line with the abolished increased suppressive capacity of Tregs, IFN-α + 1-MT-treated mice were not protected against arthritis as were mice receiving IFN-α + vehicle (Figure 4B) and as earlier reported (8). The gene discussed is IFNA1; the disease is arthritic joint disease.